9 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 12 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 12 | Completed 9, Active not recruiting 1, Recruiting 1, Terminated 1 |
Follow Takeshi Morimoto: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization Aspirin, No aspirin - Stable Angina Pectoris, Coronary Artery Disease | Phase 4 | Recruiting | Takeshi Morimoto | 2890 | 2022-06-14 | 2025-03-11 |
| Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer Long DOAC, Short DOAC - Venous Thrombosis, Neoplasms | Phase 4 | Completed | Takeshi Morimoto | 179 | 2021-02-18 | 2025-03-11 |
| GOREISAN for Heart Failure (GOREISAN-HF) Trial Goreisan, Standard Treatment - Heart Failure, Edema | Phase 4 | Active not recruiting | Takeshi Morimoto | 1179 | 2021-01-19 | 2026-01-06 |
| Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study 12-month Edoxaban, 3-month Edoxaban - Venous Thrombosis, Neoplasms | Phase 4 | Completed | Takeshi Morimoto | 605 | 2019-05-27 | 2023-10-04 |
| Short and Optimal Duration of Dual Antiplatelet Therapy Study Thienopyridine for 3 months - Coronary Artery Disease | Phase 4 | Completed | Takeshi Morimoto | 1525 | 2012-09-01 | 2015-12-10 |
| Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease intensive control, standard control - Type 2 Diabetes, Coronary Artery Disease | Phase 4 | Completed | Takeshi Morimoto | 798 | 2011-08-01 | 2024-06-14 |
| NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent Trial Biolimus-eluting stent, Everolimus-eluting stent - Coronary Artery Disease | Phase 4 | Completed | Takeshi Morimoto | 3235 | 2011-05-01 | 2015-12-10 |
| Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound control systolic blood pressure less than 120 mmHg, control systolic blood pressure less than 140 mmHg - Coronary Artery Disease, Hypertension | Phase 4 | Terminated | Takeshi Morimoto | 8 | 2010-12-01 | 2016-01-11 |
| Carvedilol Post-intervention Long-term Administration in Large-scale Trial Carvedilol, No Carvedilol - Myocardial Infarction | Phase 4 | Completed | Takeshi Morimoto | 801 | 2010-07-01 | 2017-06-27 |
| Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial follow-up coronary angiography, Clinical follow-up - Coronary Artery Disease | Phase 4 | Completed | Takeshi Morimoto | 700 | 2010-05-01 | 2017-03-15 |
| Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial Everolimus-eluting stent, Sirolimus-eluting stent - Coronary Artery Disease | Phase 4 | Completed | Takeshi Morimoto | 3206 | 2010-02-01 | 2015-12-10 |
| Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan Clopidogrel - Coronary Artery Disease | Phase 4 | Completed | Takeshi Morimoto | 106 | 2010-02-01 | 2016-01-11 |
Coronary Artery Disease (8) · Hypertension (2) · Neoplasms (2) · Venous Thrombosis (2) · Angina, Stable (1) · Diabetes Mellitus, Type 2 (1) · Dyslipidemias (1) · Edema (1) · Heart Failure (1) · Myocardial Infarction (1) · Myocardial Ischemia (1)
Aspirin (1) · Carvedilol (1) · Clopidogrel (1) · N-acetyl-S-(alpha-methyl-4-(2-methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl ester (1) · edoxaban (1) · oryeongsan (1) · thienopyridine (1)
Japan (12)
Takeshi Kimura, MD, PhD (7) · Takeshi Kimura, MD (4) · Shinichiro Ueda, MD, PhD (1)
PMID 29508236, PMID 29628128, PMID 22824435, PMID 23608784, PMID 23684673, PMID 24687156, PMID 24803436, PMID 26446596, PMID 28040445, PMID 30153268, PMID 30947938, PMID 32905623, PMID 36398903, PMID 36841318, PMID 37245250, PMID 37545171, PMID 37638968, PMID 38650055, PMID 39556015, PMID 40766276, PMID 41757461, PMID 42307155